I

IGM Biosciences, Inc.

248 employees

IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Engineered Therapeutics
Infectious Disease
Autoimmunity
Therapeutics
Cancer Immunotherapy
Inflamation
Medical
Antibody Disovery
Engineered IgM Antibodies

Date founded

2010

Funding rounds raised

Total raised

$102M

from 2 investors over 2 rounds

I

IGM Biosciences, Inc. raised $102M on July 8, 2019

Investors: Vivo Capital and Redmile Group

FAQ